Skip to main content
SpringerLink
Log in

Antiangiogenesis as a novel therapeutic concept in pediatric oncology

  • Review
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

bFGF :

Basic fibroblast growth factor

VEGF :

Vascular endothelial growth factor

References

  1. Tannock IF (1988) Tumor growth and cell kinetics. In: Tannock IF, Hill RP (eds) The basic science of oncology. Pergamon, New York, pp 140–175

    Google Scholar 

  2. Folkman J (1993) Tumor angiogenesis. In: Holland JF, Frei EF III, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine, 3rd edn. Lea & Febiger, Philadelphia, pp 153–170

    Google Scholar 

  3. Liotta LA, Stetler-Stevenson WG, Steeg PS (1993) Invasion and metastasis. In: Holland JF, Frei EF III, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine, 3rd edn. Lea & Febiger, Philadelphia, pp 138–153

    Google Scholar 

  4. Weiss L (1985) Metastatic inefficiency. In: Weiss L (ed) Principles of metastasis. Academic, Orlando, pp 134–159

    Google Scholar 

  5. Folkman J, Watson K, Ingber DE, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61

    Google Scholar 

  6. Weiss L (1985) Metastatic patterns. In: Weiss L (ed) Principles of metastasis. Academic, Orlando, pp 160–194

    Google Scholar 

  7. Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185–188

    Google Scholar 

  8. Moore KL (1989) The third week of human development. In: Moore KL (ed) Before we are born. Basic embryology and birth defects, 3rd edn. Saunders, Philadelphia, pp 43–55

    Google Scholar 

  9. Schweigerer L, Neufeld G, Friedman J, Abraham JA, Fiddes JC, Gospodarowicz D (1987) Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature 325:257–259

    Google Scholar 

  10. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934

    CAS  PubMed  Google Scholar 

  11. Schweigerer L (1993) Basic fibroblast growth factor, angiogenesis and therapeutic anti-angiogenesis. In: Dengler HJ, Meuer SC (eds) Zellbiologie und Klinische Pharmakologie. Fischer, Stuttgart, pp 91–103

    Google Scholar 

  12. Van Allen MI, Hoyme HE, Jones KL (1982) Vascular pathogenesis of limb defects. I. Radial artery anomaly in radial aplasia. J Pediatr 101:832–838

    Google Scholar 

  13. D'Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91:4082–4085

    PubMed  Google Scholar 

  14. Plate KH, Breier G, Risau W (1994) Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 4:207–218

    Google Scholar 

  15. Burri PH, Dbaly J, Weibel ER (1974) The postnatal growth of the rat lung. Morphometry. Anat Rec 178:711–730

    Google Scholar 

  16. Hudlicka O (1984) Development of microcirculation: capillary growth and adaptation. In: Renkin EM, Michel CC (eds) Handbook of physiology. The cardiovascular system, American Physiological Society, Bethesda, pp 165–216

    Google Scholar 

  17. Reynolds LP, Killilea SD, Redmer DA (1992) Angiogenesis in the female reproductive system. FASEB J 6:886–892

    Google Scholar 

  18. Hobson B, Denekamp J (1984) Endothelial proliferation in tumors and normal tissues: Continuous labeling studies. Br J Cancer 49:405–413

    Google Scholar 

  19. Schweigerer L, Fotsis T (1992) Angiogenesis and angiogenesis inhibitors in pediatric diseases. Eur J Pediatr 151:472–476

    Google Scholar 

  20. Virchow R (1863) Die krankhaften Geschwülste. Hirschwald, Berlin, pp 1–210

    Google Scholar 

  21. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409

    CAS  PubMed  Google Scholar 

  22. Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43:1089–1100

    Google Scholar 

  23. Jain RK (1991) Hemodynamic and transport barriers to the treatment of solid tumors. Int J Radiat Biol 60:85–100

    Google Scholar 

  24. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A (1994) Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst 86:1303–1314

    CAS  PubMed  Google Scholar 

  25. Schweigerer L (1988) Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue. Klin Wochenschr 66:340–345

    Google Scholar 

  26. Yamanaka Y, Friess H, Buchler M, Beger HG, Uchida E, Onda M, Kobrin MS, Korc M (1993) Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 53:5289–5296

    Google Scholar 

  27. Hughes CJ, Reed JA, Cabal R, Huvos AG, Albino AP, Schantz SP (1994) Increased expression of basic fibroblast growth factor in squamous carcinogenesis of the head and neck is less prevalent following smoking cessation. Am J Surg 168:381–385

    Google Scholar 

  28. Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095–1104

    Google Scholar 

  29. Rizzino A, Kuszynski C, Ruff E, Tiesman J (1988) Production and utilization of growth factors related to fibroblast growth factor by embryonal carcinoma cells and their differentiated cells. Dev Biol 129:61–71

    Google Scholar 

  30. Fujimoto K, Ichimori Y, Kakizoe T, Okajima E, Sakamoto H, Sugimura T, Terada M (1991) Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem Biophys Res Commun 180:386–392

    Google Scholar 

  31. Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76:792–798

    Google Scholar 

  32. Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, Friesen HG (1993) Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J Clin Endocrinol Metab 76:1182–1187

    Google Scholar 

  33. Kurobe M, Takei Y, Ezawa H, Hayashi K (1993) Increased level of basic fibroblast growth factor (bFGF) in sera of patients with malignant tumors. Horm Metab Res 25:395–396

    Google Scholar 

  34. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF, Folkman J (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86:356–361

    Google Scholar 

  35. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344:82–86

    Google Scholar 

  36. Gospodarowicz D (1991) Biological activities of fibroblast growth factors. Ann NY Acad Sci 638:1–8

    Google Scholar 

  37. Ferrara N (1993) Vascular endothelial growth factor. Trends Cardiovasc Med 3:244–250

    Google Scholar 

  38. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo K-T, Yeo T-K, Berse B, Jackman RW, Dvorak AM, Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303–324

    Google Scholar 

  39. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822–5827

    Google Scholar 

  40. Hattori Y, Odagiri H, Nakatani H, Miyagawa K, Naito K, Sakamoto H, Katoh O, Yoshida T, Sugimura T, Terada M (1990) K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci USA 87:5983–5987

    Google Scholar 

  41. Saito H, Kasayama S, Kouhara H, Matsumoto K, Sato B (1991) Up-regulation of fibroblast growth factor (FGF) receptor mRNA levels by basic FGF or testosterone in androgen-sensitive mouse mammary tumor cells. Biochem Biophys Res Commun 174:136–141

    Google Scholar 

  42. Morrison RS, Yamaguchi F, Bruner JM, Tang M, McKeehan W, Berger MS (1994) Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 54:2794–2799

    Google Scholar 

  43. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318–1327

    Google Scholar 

  44. Davidoff AM, Pence JC, Shorter NA, Iglehart JD, Marks JR (1992) Expression of 53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene 7:127–133

    Google Scholar 

  45. Imamura J, Bartram CR, Berthold F, Harms D, Nakamura H, Koeffler HP (1993) Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 53:4053–4058

    Google Scholar 

  46. Hosoi G, Hara J, Okamura T, Osugi Y, Ishihara S, Fukuzawa M, Okada A, Okada S, Tawa A (1994) Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73:3087–3093

    Google Scholar 

  47. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Hanada R, Yamamoto K, Hongo T, Yamada M, Tsuchida Y (1993) Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53:5284–5288

    Google Scholar 

  48. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen A-L, Yan YX, Russo C, Sato J, Barbier N, Miser J, Malkin D, Gebhardt MC (1994) Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J Clin Oncol 12:925–930

    Google Scholar 

  49. Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265:1582–1584

    Google Scholar 

  50. Van Meir EG, Polverini PJ, Chazin VR, Su Huang H-J, De Tribolet N, Cavenee WK (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nature Genet 8:171–176

    Google Scholar 

  51. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? JNCI 82:4–7

    Google Scholar 

  52. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T, Kozai Y (1991) Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51:6180–6184

    Google Scholar 

  53. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominantnegative Flk-1 mutant. Nature 367:576–579

    Article  CAS  PubMed  Google Scholar 

  54. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362:841–844

    Article  Google Scholar 

  55. Schweigerer L, Neufeld G, Gospodarowicz D (1987) Basic fibroblast growth factor is present in cultured human retinoblastoma cells. Invest Ophtalmol Vis Sci 28:1838–1843

    Google Scholar 

  56. Levy AP, Tamargo R, Brem H, Nathans D (1989) An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2:9–19

    Google Scholar 

  57. Schweigerer L, Neufeld G, Gospodarowicz D (1987) Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J Clin Invest 80:1516–1520

    Google Scholar 

  58. Raney B Jr, Tefft M, Maurer HM, Ragab AH, Hays DM, Soule EH, Foulkes MA, Gehan EA (1988) Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. Cancer 62:1257–1266

    Google Scholar 

  59. Burger MM, Folkman J (1994) UICC Study Group on basic and clinical cancer research: tumor angiogenesis. Int J Cancer 56:311–313

    Google Scholar 

  60. Ribatti D, Vacca A, Bertossi M, De Benedictis G, Roncali L, Dammacco F (1990) Angiogenesis induced by B-cell non-Hodgkin's lymphoms — lack of correlation with tumor malignancy and immunological phenotype. Anticancer Res 10:401–408

    Google Scholar 

  61. Baguley BC, Holdaway KM, Thomsen LL, Zhuang L, Zwi LJ (1991) Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism. Eur J Cancer 27:482–487

    Google Scholar 

  62. Evans RR, Calmels TP, Pitt BR, Brookens MA, Johnson CS, Modzelewski RA, Lazo JS (1994) Gene therapy and endothelial cell targeting for cancer. Ann NY Acad Sci 716:257–264

    Google Scholar 

  63. Brem H, Gresser I, Grosfeld J, Folkman J (1993) The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28:1253–1257

    Google Scholar 

  64. Teicher BA, Holden SA, Ara G, Alvarez Sotomayor E, Huang ZD, Chen Y-N, Brem H (1994) Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents. Int J Cancer 57:920–925

    Google Scholar 

  65. Lazo JS (1986) Endothelial injury caused by antineoplastic agents. Biochem Pharmacol 35:1919–1923

    Google Scholar 

  66. Auerbach R, Modzelewski RA, Plendl J, Wang S-J (1994) From primitive embryonic precursor cells to organ- and tumor-specific vascular endothelial cells: a progress report. Proc Am Ass Cancer Res 35:663

    Google Scholar 

  67. Burrows FJ, Thorpe PE (1994) Vascular targeting-A new approach to the therapy of solid tumors. Pharmacol Ther 64:155–174

    Google Scholar 

  68. Callow AD (1990) The vascular endothelial cell as a vehicle for gene therapy. J Vasc Surg 11:793–798

    Google Scholar 

  69. Harris AL, Fox S, Bicknell R, Leek R, Relf M, LeJeune S, Kaklamanis L (1994) Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. Cancer 74 [Suppl]:1021–1025

    Google Scholar 

  70. Hirata S, Matsubara T, Saura R, Tateishi H, Hirohata K (1989) Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum 32:1065–1073

    Google Scholar 

  71. Goldacre R, Sylven B (1962) On the access of blood-borne dyes to various tumor regions. Br J Cancer 16:306–311

    Google Scholar 

  72. Denekamp J, Hill SA, Hobson B (1983) Vascular occlusion and tumor cell death. Eur J Cancer Clin Oncol 19:271–275

    Google Scholar 

  73. Otte J (1988) Hyperthermia in cancer therapy. Eur J Pediatr 147:560–569

    Google Scholar 

  74. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1:27–31

    Google Scholar 

  75. Teicher BA, Holden SA, Ara G, Northey D (1993) Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents. Anticancer Res 13:2101–2106

    Google Scholar 

  76. Monti E, Sinha BK (1994) Antiproliferative effect of genistein and adriamycin against estrogen-dependent and-independent human breast carcinoma cell lines. Anticancer Res 14:1221–1226

    Google Scholar 

  77. Kato T, Sato K, Kakinuma H, Matsuda Y (1994) Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res 54:5143–5147

    Google Scholar 

  78. Teicher BA, Alvarez Sotomayor E, Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702–6704

    Google Scholar 

  79. Milas L, Hunter N, Furuta Y, Nishiguchi I, Runkel S (1991) Antitumour effects of indomethacin alone and in combination with radiotherapy: role of inhibition of tumour angiogenesis. Int J Radiat Biol 60:65–70

    Google Scholar 

  80. Steel GG, Wheldon TE (1992) The radiation biology of pediatric tumors. In: Plowman PN, Pinkerton CR (eds) Pediatric oncology. Clinical practice and controversies. Chapman & Hall Medical, London, pp 73–86

    Google Scholar 

  81. Murray JC, Randhawa V, Denekamp J (1987) The effects of melphalan and misonidazole on the vasculature of murine sarcoma. Br J Cancer 55:233–238

    Google Scholar 

  82. Auerbach W, Auerbach R (1994) Angiogenesis inhibition: a review. Pharmacol Ther 63:265–311

    Google Scholar 

  83. Gasparini G, Harris AL (1994) Does improved control of tumour growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? Eur J Cancer 30A:201–206

    Google Scholar 

  84. Pierson HF (1993) Diet, Chemoprevention and Cancer. In: Holland JF, Frei EF III, Bast RC, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine, 3rd edn. Lea & Febiger, Philadelphia, pp 396–407

    Google Scholar 

  85. Lamartiniere CA, Moore J, Holland M, Barnes S (1995) Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 208:120–123

    Google Scholar 

  86. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, Schweigerer L (1993) Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 90:2690–2694

    Google Scholar 

  87. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L (1994) The endogenous estrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 368:237–239

    Google Scholar 

  88. Edwards MSB, Prados M (1987) Current management of brain stem gliomas. Pediatr Neurosci 13:309–315

    Google Scholar 

  89. Denekamp J (1990) Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev 9:267–282

    Google Scholar 

  90. White CW (1990) Treatment of hemangiomatosis with recombinant interferon alpha. Semin Hematol 27:15–22

    Google Scholar 

  91. Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326:1456–1463

    Google Scholar 

  92. Kerbel RS (1991) Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anticancer agents. Bioessays 13:31–36

    Google Scholar 

  93. Schweigerer L (1988) Basic fibroblast growth factor as a wound healing hormone. Trends Pharmacol Sci 9:427–428

    Google Scholar 

  94. Fiddes JC, Hebda PA, Hayward P, Robson MC, Abraham JA, Klingbeil CK (1991) Preclinical wound-healing studies with recombinant human basic fibroblast growth factor. Ann NY Acad Sci 638:316–328

    Google Scholar 

  95. Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    Google Scholar 

  96. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA (1992) Relation of neovascularization to metastasis of non-small-cell lung cancer. Lancet 340:145–146

    Google Scholar 

  97. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1887

    Google Scholar 

  98. Olivarez D, Ulbright T, DeRiese W, Foster R, Reister T, Einhorn L, Sledge G (1994) Neovascularization in clinical stage A testicular germ cell tumor: Prediction of metastatic disease. Cancer Res 54:2800–2802

    Google Scholar 

  99. Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 168:373–380

    Google Scholar 

  100. Barritault D, Groux-Muscatelli B, Caruelle D, Voisin M-C, Chopin D, Palcy S, Caruelle J-P (1991) aFGF content increases with malignancy in human chondrosarcoma and bladder cancer. Ann NY Acad Sci 638:387–393

    Google Scholar 

  101. Takei Y, Kurobe M, Uchida A, Hayashi K (1994) Serum concentrations of basic fibroblast growth factor in breast cancer. Clin Chem 40:1980–1981

    Google Scholar 

  102. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255–1262

    Google Scholar 

  103. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta Mol Cell Res 1221:211–214

    Google Scholar 

  104. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M (1994) Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233–4237

    Google Scholar 

  105. Fujiwara T, Grimm EA, Roth JA (1994) Gene therapeutics and gene therapy for cancer. Curr Opin Oncol 6:96–105

    Google Scholar 

  106. Malkin D, Portwine C (1994) The genetics of childhood cancer. Eur J Cancer 30A:1942–1946

    Google Scholar 

  107. Uckert W, Walther W (1994) Retrovirus-mediated gene transfer in cancer therapy. Pharmacol Ther 63:323–347

    Google Scholar 

  108. Kondo S, Asano M, Suzuki H (1993) Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochem Biophys Res Commun 194:1234–1241

    Google Scholar 

  109. Neufeld G, Gospodarowicz D (1987) Protamine sulfate inhibits mitogenic activities of the extracellular matrix and fibroblast growth factor, but potentiates that of epidermal growth factor. J Cell Physiol 132:287–294

    Google Scholar 

  110. Huang JS, Huang SS, Kuo M-D (1986) Bovine brain-derived growth factor. Purification and characterization of its interaction with responsive cells. J Biol Chem 261:11600–11607

    Google Scholar 

  111. Coffey RJ Jr, Leof EB, Shipley GD, Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132:143–148

    Google Scholar 

  112. Vaisman N, Gospodarowicz D, Neufeld G (1990) Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265:19461–19466

    Google Scholar 

  113. Rastinejad F, Polverini P, Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345–355

    Article  Google Scholar 

  114. Brown KJ, Parish CR (1994) Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor. Biochemistry 33:13918–13927

    Google Scholar 

  115. Baird A, Schubert D, Ling N, Guillemin R (1988) Receptorand heparin-binding domains of basic fibroblast growth factor. Proc Natl Acad Sci USA 85:2324–2328

    Google Scholar 

  116. Yayon A, Aviezer D, Safran M, Gross JL, Heldman Y, Cabilly S, Givol D, Katchalski-Katzir E (1993) Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc Natl Acad Sci USA 90:10643–10647

    Google Scholar 

  117. Jellinek D, Lynott CK, Rifkin DB, Janjic N (1993) High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci USA 90:11227–11231

    Google Scholar 

  118. Jellinek D, Green LS, Bell C, Janjic N (1994) Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry 33:10450–10456

    Google Scholar 

  119. D'Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964–3968

    Google Scholar 

  120. McCarthy SA, Bicknell R (1993) Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 268:23066–23071

    Google Scholar 

  121. Ingber DE, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348:555–557

    Article  Google Scholar 

  122. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315–328

    Article  PubMed  Google Scholar 

  123. Matsubara T, Saura R, Hirohata K, Ziff M (1989) Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by d-penicillamin. J Clin Invest 83:158–167

    Google Scholar 

  124. Matsubara T, Ziff M (1987) Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest 79:1440–1446

    Google Scholar 

  125. Ferrara N, Clapp C, Weiner R (1991) The 16 K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896–900

    Google Scholar 

  126. Sharon P, Drab EA, Linder JS, Weidman SW, Sabesin SM, Rubin DB (1992) The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution: Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine. J Lab Clin Med 119:99–107

    Google Scholar 

  127. Gagliardi A, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 53:533–535

    Google Scholar 

  128. Bagavandoss P, Wilks JW (1990) Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun 170:867–872

    Google Scholar 

  129. Murphy AN, Unsworth EJ, Stetler-Stevenson WG (1993) Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 157:351–358

    Google Scholar 

  130. Schweigerer L, Malerstein B, Gospodarowicz D (1987) Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells. Biochem Biophys Res Commun 143:997–1004

    Google Scholar 

  131. Brouty-Boyé D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516–518

    Google Scholar 

  132. Pepper MS, Vassalli J-D, Wilks JW, Schweigerer L, Orci L, Montesano R (1994) Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis in vitro. J Cell Biochem 55:419–434

    Google Scholar 

  133. Sato Y, Abe M, Takaki R (1990) Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 172:595–600

    Google Scholar 

  134. Hasselaar P, Sage EH (1992) SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem 49:272–283

    Google Scholar 

  135. Taraboletti G, Roberts D, Liotta LA, Giavazzi R (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol 111:765–772

    Google Scholar 

  136. Avery RL, Connor TB Jr, Farazdaghi M (1990) Systemic amiloride inhibits experimentally induced neovascularization. Arch Ophthalmol 108:1474–1476

    Google Scholar 

  137. Alliegro MC, Alliegro MA, Cragoe EJ Jr, Glaser BM (1993) Amiloride inhibition of angiogenesis in vitro. J Exp Zool 267:245–252

    Google Scholar 

  138. Ingber DE, Madri JA, Folkman J (1986) A possible mechanism for inhibition of angiogenesis by angiostatic steroids: Induction of basement membrane dissolution. Endocrinology 119:1768–1775

    Google Scholar 

  139. Moses MA, Sudhalter J, Langer R (1990) Identification of an inhibitor of neovascularization from cartilage. Science 248:1408–1410

    Google Scholar 

  140. Rosenthal RA, Moses MA, Shintani Y, Megyesi JF, Langer R, Folkman J (1994) Purification and characterization of two collagenase inhibitors from mouse sarcoma 180 conditioned medium. J Cell Biochem 56:97–105

    Google Scholar 

  141. Wolff JEA, Guerin C, Laterra J, Bressler J, Indurti RR, Brem H, Goldstein GW (1993) Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors. Brain Res 604:79–85

    Google Scholar 

  142. Tamargo RJ, Bok RA, Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51:672–675

    Google Scholar 

  143. Blei F, Wilson EL, Mignatti P, Rifkin DB (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 144:568–578

    Google Scholar 

  144. Ingber DE, Folkman J (1988) Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59:44–51

    Google Scholar 

  145. Murata J, Saiki I, Makabe T, Tsuta Y, Tokura S, Azuma I. (1991) Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res 51:22–26

    Google Scholar 

  146. Robaye B, Mosselmans R, Fiers W, Dumont JE, Galand P (1991) Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138:447–453

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Kinderklinik, Philipps-Universität Marburg, Deutschhausstrasse 12, D-35033, Marburg, Germany

    L. Schweigerer

Authors
  1. L. Schweigerer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schweigerer, L. Antiangiogenesis as a novel therapeutic concept in pediatric oncology. J Mol Med 73, 497–508 (1995). https://doi.org/10.1007/BF00198901

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00198901

Key words

Search

Navigation